However, available treatments have failed to show novel approaches and effectiveness, and the efficacy of drugs varies from one person to another.37 GSK-3β expression levels increase with age and are most abundant and hyperactive in the brains of patients with AD. The gene discussed is GSK3B; the disease is Alzheimer disease.